Protara Therapeutics, Inc. (TARA) Misses Q4 EPS by 2c

Protara Therapeutics, Inc. (NASDAQ: TARA) reported Q4 EPS of ($0.37), $0.02 worse than the analyst estimate of ($0.35).

For earnings history and earnings-related data on Protara Therapeutics, Inc. (TARA) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• Kaiser Aluminum names Fred Stephan as CEO, effective November 2026
• Wendy's U.S. president to resign, company to create COO role